創新醫療(002173.SZ)已累計收到珍珠資產股權轉讓款總額的75.83%
格隆匯11月24日丨創新醫療(002173.SZ)公佈,公司第五屆董事會2018年第五次臨時會議和2018年第一次臨時股東大會審議通過了《關於同意向公司關聯人轉讓相關珍珠資產暨關聯交易的議案》,同意公司向關聯人陳夏英、陳海軍以人民幣3.79億元轉讓相關珍珠業務資產。
截至2018年12月5日,公司共計收到相關珍珠資產股權轉讓款項2.27億元,即股權轉讓款總額3.79億元的60%,其中陳夏英支付1.82億元,陳海軍支付4548.62萬元。其後,公司已配合陳夏英、陳海軍完成相關珍珠資產股權變更登記手續,並按照約定,陳夏英、陳海軍將已過户至其名下的相關珍珠資產100%股權質押給公司。
2019年11月21日,公司收到關聯人陳夏英、陳海軍支付的珍珠資產股權轉讓款2000萬元及利息33.83萬元,其中陳夏英支付1600萬元及利息27.07萬元,陳海軍支付400萬元及利息6.77萬元,至此公司收到陳夏英、陳海軍支付的股權轉讓款共計約2.87億元,即股權轉讓款總額3.79億的75.83%,其中陳夏英支付約2.30億元,陳海軍支付5748.62萬元。公司收到陳夏英、陳海軍支付的利息共計61.14萬元,其中陳夏英支付利息48.91萬元,陳海軍支付利息12.23萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.